TABLE 1

Effect of zileuton racemate on various P450 activities in human liver microsomes in the absence of preincubation

Duplicate IC50 values were obtained using human liver microsomes. In each case, the inhibition was compared with a solvent-alone control. IC50 values were obtained at a single concentration of substrate (paclitaxel, 15 μM; phenacetin, 100 μM; diclofenac, 10 μM; (S)-mephenytoin, 80 μM; bufuralol, 15 μM; testosterone, 50 μM; chlorzoxazone, 200 μM; and bupropion, 100 μM) as described under Materials and Methods. The percentage inhibition observed at the highest concentration of zileuton tested (100 μM) was <5% (CYP2D6 and CYP2C8), ∼15% (CYP1A2, CYP2E1, and CYP2C9), 40% (CYP2B6 and CYP3A4), and 45% (CYP2C19).


P450 Form

Reaction

Test Article

IC50
1
2
μM
CYP1A2 Phenacetin O-deethylation Fluvoxamine 0.4 0.4
Zileuton >100 >100
CYP2C8 Paclitaxel 6α-hydroxylation Quercetin 3.5 4.8
Zileuton >100 >100
CYP2C9 Diclofenac 4′-hydroxylation Sulfaphenazole 0.5 0.5
Zileuton >100 >100
CYP2C19 (S)-Mephenytoin 4′-hydroxylation (R)-N-3-Benzylphenobarbital 0.3 0.3
Zileuton >100 >100
CYP2D6 Bufuralol 1′-hydroxylation Quinidine 0.1 0.1
Zileuton >100 >100
CYP3A4 Testosterone 6β-hydroxylation Ketoconazole 0.02 0.05
Zileuton >100 >100
CYP2B6 Bupropion hydroxylation N-(α-Methylbenzyl)-1-aminobenzotriazole 0.03 0.05
Zileuton >100 >100
CYP2E1 Chlorzoxazone 6-hydroxylation 4-Methylpyrazole 3.0 1.79


Zileuton
>100
>100